biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI tweets:

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 16, 2023 4:09pm

79 Views

Post# 35451033

RE:RE:RE:BTI tweets:

Lol, poof, mid day today was accurate. You got it wrong. More to the point is your long time habit of trying to use guidance as an accurate prediction. You've always held Bioasis responsible for this type of non-specific type of guidance.

We know why you do it. As a trader, when you start buying again, you'll use anything to scare investors into selling. You were telling us that the financial cliff was on Monday. The fact that you got it wrong was funny.

But in the end, we know what you were doing. You were trying to help your buying.

Just you being you.

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario